(19)
(11) EP 4 313 019 A1

(12)

(43) Date of publication:
07.02.2024 Bulletin 2024/06

(21) Application number: 22782422.4

(22) Date of filing: 31.03.2022
(51) International Patent Classification (IPC): 
A61K 31/196(2006.01)
A61K 9/16(2006.01)
 A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/196; A61K 9/2018; A61K 9/2054; A61K 9/2095; A61K 45/06; A61K 31/46; A61K 31/137
 
C-Sets:
  1. A61K 31/196, A61K 2300/00;
  2. A61K 31/46, A61K 2300/00;
  3. A61K 31/137, A61K 2300/00;
(86) International application number:
PCT/US2022/071462
(87) International publication number:
WO 2022/213103 (06.10.2022 Gazette 2022/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 31.03.2021 US 202163168817 P

(71) Applicant: B3AR Therapeutics, Inc.
Palo Alto, CA 94301 (US)

(72) Inventors:
  • STEVENS, JR., Raymond E.
    Chester, Pennsylvania 19382 (US)
  • BENNYHOFF, Dale
    Devon, Pennsylvania 19333 (US)

(74) Representative: Wright, Simon Mark 
Schlich Ltd 9 St. Catherine's Road
Littlehampton, West Sussex BN17 5HS
Littlehampton, West Sussex BN17 5HS (GB)

   


(54) COMPOSITIONS OF MICRONIZED SOLABEGRON AND METHODS OF USE